Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

RANK receptor oligomerisation in the regulation of NFκB signalling.

Das S, Sepahi I, Duthie A, Clark S, Crockett JC.

J Mol Endocrinol. 2014 Aug;53(1):81-91. doi: 10.1530/JME-14-0077. Epub 2014 May 23.

2.

Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells.

Das S, Edwards PA, Crockett JC, Rogers MJ.

Biochim Biophys Acta. 2014 Apr 4;1841(4):569-73. doi: 10.1016/j.bbalip.2013.12.010. Epub 2013 Dec 22.

PMID:
24369118
3.

Osteoporosis - a current view of pharmacological prevention and treatment.

Das S, Crockett JC.

Drug Des Devel Ther. 2013 May 31;7:435-48. doi: 10.2147/DDDT.S31504. Print 2013. Review.

4.

RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.

Pangrazio A, Cassani B, Guerrini MM, Crockett JC, Marrella V, Zammataro L, Strina D, Schulz A, Schlack C, Kornak U, Mellis DJ, Duthie A, Helfrich MH, Durandy A, Moshous D, Vellodi A, Chiesa R, Veys P, Lo Iacono N, Vezzoni P, Fischer A, Villa A, Sobacchi C.

J Bone Miner Res. 2012 Feb;27(2):342-51. doi: 10.1002/jbmr.559.

5.

Transfection of osteoclasts and osteoclast precursors.

Crockett JC, Mellis DJ, Taylor A.

Methods Mol Biol. 2012;816:205-22. doi: 10.1007/978-1-61779-415-5_14.

PMID:
22130931
6.

Isolation and purification of rabbit osteoclasts.

Coxon FP, Rogers MJ, Crockett JC.

Methods Mol Biol. 2012;816:145-58. doi: 10.1007/978-1-61779-415-5_10.

PMID:
22130927
7.

Absence of glutamine supplementation prevents differentiation of murine calvarial osteoblasts to a mineralizing phenotype.

Brown PM, Hutchison JD, Crockett JC.

Calcif Tissue Int. 2011 Dec;89(6):472-82. doi: 10.1007/s00223-011-9537-6. Epub 2011 Oct 5.

PMID:
21972050
8.

The skeleton: a multi-functional complex organ: the role of key signalling pathways in osteoclast differentiation and in bone resorption.

Mellis DJ, Itzstein C, Helfrich MH, Crockett JC.

J Endocrinol. 2011 Nov;211(2):131-43. doi: 10.1530/JOE-11-0212. Epub 2011 Sep 8. Review.

PMID:
21903860
9.

The thyroid nodule: fine-needle aspiration biopsy technique.

Crockett JC.

J Ultrasound Med. 2011 May;30(5):685-94.

PMID:
21527617
10.

Signal peptide mutations in RANK prevent downstream activation of NF-κB.

Crockett JC, Mellis DJ, Shennan KI, Duthie A, Greenhorn J, Wilkinson DI, Ralston SH, Helfrich MH, Rogers MJ.

J Bone Miner Res. 2011 Aug;26(8):1926-38. doi: 10.1002/jbmr.399.

11.

Bone remodelling at a glance.

Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH.

J Cell Sci. 2011 Apr 1;124(Pt 7):991-8. doi: 10.1242/jcs.063032. No abstract available.

12.

Biochemical and molecular mechanisms of action of bisphosphonates.

Rogers MJ, Crockett JC, Coxon FP, Mönkkönen J.

Bone. 2011 Jul;49(1):34-41. doi: 10.1016/j.bone.2010.11.008. Epub 2010 Nov 26. Review.

PMID:
21111853
13.

New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.

Crockett JC, Mellis DJ, Scott DI, Helfrich MH.

Osteoporos Int. 2011 Jan;22(1):1-20. doi: 10.1007/s00198-010-1272-8. Epub 2010 May 11. Review.

PMID:
20458572
14.

Increase in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease.

Ng MT, Van't Hof R, Crockett JC, Hope ME, Berry S, Thomson J, McLean MH, McColl KE, El-Omar EM, Hold GL.

Infect Immun. 2010 Mar;78(3):1345-52. doi: 10.1128/IAI.01226-09. Epub 2009 Dec 28.

15.

Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.

Räikkönen J, Crockett JC, Rogers MJ, Mönkkönen H, Auriola S, Mönkkönen J.

Br J Pharmacol. 2009 Jun;157(3):427-35. doi: 10.1111/j.1476-5381.2009.00160.x. Epub 2009 Apr 3.

16.

Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.

Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P, Coxon FP, Helfrich MH, Crockett JC, Mellis D, Vellodi A, Tezcan I, Notarangelo LD, Rogers MJ, Vezzoni P, Villa A, Frattini A.

Am J Hum Genet. 2008 Jul;83(1):64-76. doi: 10.1016/j.ajhg.2008.06.015.

17.

A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.

Hughes A, Rogers MJ, Idris AI, Crockett JC.

Calcif Tissue Int. 2007 Nov;81(5):403-13. Epub 2007 Nov 3.

PMID:
17982704
18.

The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.

Crockett JC, Schütze N, Tosh D, Jatzke S, Duthie A, Jakob F, Rogers MJ.

Endocrinology. 2007 Dec;148(12):5761-8. Epub 2007 Sep 6.

PMID:
17823253
19.

Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.

Thompson K, Rogers MJ, Coxon FP, Crockett JC.

Mol Pharmacol. 2006 May;69(5):1624-32. Epub 2006 Feb 24.

PMID:
16501031
20.

Introgenic obscuration of radiologic findings deserves second look.

Crockett JC, Aben G.

J Am Osteopath Assoc. 1998 Oct;98(10):540-1. No abstract available.

PMID:
9821734

Supplemental Content

Loading ...
Support Center